Enhabit, Inc. $EHAB Shares Sold by State of Wyoming

State of Wyoming cut its position in Enhabit, Inc. (NYSE:EHAB) by 33.1% during the first quarter, HoldingsChannel.com reports. The fund owned 47,707 shares of the company’s stock after selling 23,600 shares during the period. State of Wyoming’s holdings in Enhabit were worth $419,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the company. GAMMA Investing LLC raised its stake in Enhabit by 295.2% in the 1st quarter. GAMMA Investing LLC now owns 3,533 shares of the company’s stock valued at $31,000 after purchasing an additional 2,639 shares during the last quarter. Group One Trading LLC grew its holdings in shares of Enhabit by 248.3% during the fourth quarter. Group One Trading LLC now owns 7,746 shares of the company’s stock worth $60,000 after buying an additional 5,522 shares in the last quarter. CWM LLC raised its position in shares of Enhabit by 383.6% in the first quarter. CWM LLC now owns 11,738 shares of the company’s stock valued at $103,000 after buying an additional 9,311 shares during the last quarter. Boothbay Fund Management LLC purchased a new position in shares of Enhabit in the fourth quarter worth about $106,000. Finally, ProShare Advisors LLC purchased a new position in shares of Enhabit in the fourth quarter worth about $110,000.

Insider Activity at Enhabit

In other Enhabit news, CFO Ryan Solomon acquired 10,000 shares of the firm’s stock in a transaction that occurred on Friday, August 8th. The shares were purchased at an average cost of $7.64 per share, for a total transaction of $76,400.00. Following the completion of the acquisition, the chief financial officer owned 193,468 shares of the company’s stock, valued at approximately $1,478,095.52. The trade was a 5.45% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 3.40% of the company’s stock.

Enhabit Trading Down 0.3%

Shares of EHAB stock opened at $7.90 on Friday. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.79. Enhabit, Inc. has a twelve month low of $6.47 and a twelve month high of $10.90. The company’s 50-day moving average price is $7.57 and its 200-day moving average price is $8.48. The stock has a market cap of $400.20 million, a price-to-earnings ratio of -2.96 and a beta of 1.68.

Enhabit (NYSE:EHAB) last released its quarterly earnings data on Wednesday, August 6th. The company reported $0.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.03. The firm had revenue of $266.10 million during the quarter, compared to analysts’ expectations of $263.39 million. Enhabit had a negative net margin of 12.84% and a positive return on equity of 2.72%. As a group, equities analysts predict that Enhabit, Inc. will post 0.22 earnings per share for the current year.

Analysts Set New Price Targets

Separately, UBS Group cut their price objective on shares of Enhabit from $10.00 to $8.50 and set a “neutral” rating for the company in a report on Friday, August 8th. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $8.67.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.